MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

02 Nov 2022 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a press release today titled ‘Glenmark Pharmaceuticals receives ANDA approval for Sodium Phenylbutyrate Tablets USP, 500 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..